$OVID
Ovid Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.70
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOvid Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is OVID up today? It is at $2.70 (+0.00%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OVID spikes, and full due diligence on OVID — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OVID 54 times in the last 30 days. Create a free account to track $OVID, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OVID from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OVID today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carter Charles Ross Officer | Acquired (grant/award) | +50K 0.03% of company | added 100% | 94K | n/a | Jul 6, 26 |
Friedman Bart Director | Acquired (grant/award) | +9K | n/a | 9K | $22K at $2.56 | Apr 7, 26 |
Fitzgerald Kevin Joseph Director | Acquired (grant/award) | +18K | n/a | 18K | $45K at $2.56 | Apr 7, 26 |
Papadopoulos Stelios Director | Acquired (grant/award) | +18K | added 8.8% | 218K | $45K at $2.56 | Apr 7, 26 |
Levin Jeremy M Officer | Other | 47K 0.02% of company | added 1.3% | 3.74M | $66K at $1.40 | Mar 23, 26 |
Rona Jeffrey A Officer | Acquired (grant/award) | +68K 0.03% of company | added 77% | 156K | n/a | Feb 26, 26 |
Rona Jeffrey A Officer | Sold (automatic/other) | -9K | sold 8.8% | 88K | $12K at $1.45 | Feb 23, 26 |
Alexander Margaret A. Officer | Sold (automatic/other) | -12K | sold 16% | 62K | $17K at $1.45 | Feb 23, 26 |
Levin Jeremy M Officer | Acquired (grant/award) | +71K 0.04% of company | added 2.0% | 3.69M | n/a | Dec 15, 25 |
Takeda Pharmaceutical Co Ltd Beneficial Owner (10%) | Acquired (grant/award) | +1.25M 0.6% of company | added 22% | 7.00M | n/a | Dec 8, 25 |
Rona Jeffrey A Officer | Sold (automatic/other) | -4K | sold 5.4% | 68K | $2K at $0.560 | Feb 26, 25 |
Alexander Margaret A. Officer | Sold (automatic/other) | -5K | sold 6.7% | 73K | $3K at $0.560 | Feb 26, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on OVID from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OVID today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
OVID last traded at $2.70, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Ovid Therapeutics Inc. Common Stock (OVID) is next expected to report earnings on Wednesday, November 11, 2026, about 54 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The OVID Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OVID 54 times in the last 30 days.
OVID (Ovid Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $523M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OVID for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OVID discussion
Sign in to ask a question or join the discussion.